Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Apple Inc. (AAPL) Stock Is More Than iPhone 8

Apple (AAPL) is healthy beyond iPhone 8 and smartphones, as development in autonomous driving is a potential driver for Apple stock.

Tesla Inc (TSLA) Stock Has Nothing to Worry About

Despite a few stumbles, Tesla's (TSLA) prospects with its upcoming releases are strong, and so is TSLA stock.

Microsoft Corporation (MSFT) Stock Is a Buy, Regardless of Earnings

Microsoft (MSFT) has been forging alliances and innovating, making MSFT stock look appealing regardless of what Thursday's Q3 report brings.

Advanced Micro Devices, Inc. (AMD) Stock’s Ryzen 5 Is a Game Changer

AMD released the Ryzen 5, a CPU that targets the mainstream market, which should give an edge to Advanced Micro Devices.

Why Facebook Inc (FB) Stock Still Has Nothing to Fear From Snapchat

Snapchat is hardly a threat to FB stock, but that will not stop the Facebook from playing hardball. Here's what you need to know.